z-logo
open-access-imgOpen Access
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders
Author(s) -
Andrea Marıno,
Daniele Scuderi,
Maria Elena Locatelli,
Adele Gentile,
Alessio Pampaloni,
Federica Cosentino,
Manuela Ceccarelli,
Benedetto Maurizio Celesia,
F. Benanti,
Giuseppe Nunnari,
Arturo Montineri,
Bruno Cacopardo
Publication year - 2020
Publication title -
hepatitis monthly
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.264
H-Index - 37
eISSN - 1735-3408
pISSN - 1735-143X
DOI - 10.5812/hepatmon.95101
Subject(s) - neurocognitive , medicine , cohort , brain derived neurotrophic factor , neurotrophic factors , psychiatry , cognition , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom